Christian Torp-Pedersen
Christian Torp-Pedersen
Professor of cardiology and clinical epidemiology, Aalborg University and department of Cardiology
Verificeret mail på heart.dk
Citeret af
Citeret af
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised …
PA Poole-Wilson, K Swedberg, JGF Cleland, A Di Lenarda, P Hanrath, ...
The Lancet 362 (9377), 7-13, 2003
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
A clinical trial of the angiotensin-converting–enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
L Køber, C Torp-Pedersen, JE Carlsen, H Bagger, P Eliasen, K Lyngborg, ...
New England Journal of Medicine 333 (25), 1670-1676, 1995
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ...
The Lancet 355 (9215), 1575-1581, 2000
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population
T Willum Hansen, JA Staessen, C Torp-Pedersen, S Rasmussen, L Thijs, ...
Circulation 113 (5), 664-670, 2006
Defibrillator implantation in patients with nonischemic systolic heart failure
L Køber, JJ Thune, JC Nielsen, J Haarbo, L Videbæk, E Korup, G Jensen, ...
New England Journal of Medicine 375 (13), 1221-1230, 2016
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
JB Olesen, GYH Lip, ML Hansen, PR Hansen, JS Tolstrup, J Lindhardsen, ...
Bmj 342, 2011
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors:‘establishing normal and reference values’
Reference Values for Arterial Stiffness' Collaboration
European heart journal 31 (19), 2338-2350, 2010
2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of …
H Baumgartner, J De Backer, SV Babu-Narayan, W Budts, M Chessa, ...
European heart journal 42 (6), 563-645, 2021
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, ...
European heart journal 26 (7), 650-661, 2005
Effect of dronedarone on cardiovascular events in atrial fibrillation
SH Hohnloser, HJGM Crijns, M van Eickels, C Gaudin, RL Page, ...
New England Journal of Medicine 360 (7), 668-678, 2009
Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest
M Wissenberg, FK Lippert, F Folke, P Weeke, CM Hansen, ...
Jama 310 (13), 1377-1384, 2013
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and …
SJ Connolly, J Pogue, J Eikelboom, G Flaker, P Commerford, ...
Circulation 118 (20), 2029-2037, 2008
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects
WPT James, ID Caterson, W Coutinho, N Finer, LF Van Gaal, ...
New England Journal of Medicine 363 (10), 905-917, 2010
Increased mortality after dronedarone therapy for severe heart failure
L Køber, C Torp-Pedersen, JJV McMurray, O Gøtzsche, S Lévy, H Crijns, ...
New England Journal of Medicine 358 (25), 2678-2687, 2008
Dofetilide in patients with congestive heart failure and left ventricular dysfunction
C Torp-Pedersen, M Møller, PE Bloch-Thomsen, L Køber, E Sandøe, ...
New England Journal of Medicine 341 (12), 857-865, 1999
Stroke and bleeding in atrial fibrillation with chronic kidney disease
JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ...
New England Journal of Medicine 367 (7), 625-635, 2012
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ...
Archives of internal medicine 170 (16), 1433-1441, 2010
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20